Related Experiment Video
Updated: Feb 2, 2026

A "Patient-Like" Orthotopic Syngeneic Mouse Model of Hepatocellular Carcinoma Metastasis
Published on: October 24, 2015
YTHDF2 suppresses cell proliferation and growth via destabilizing the EGFR mRNA in hepatocellular carcinoma
Li Zhong1, Dan Liao1, Meifang Zhang1
1State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
Abstract:
N6-methyladenosin (m6A) is one of the most pervasive modification of mRNA in eukaryotes and the m6A methyltransferases and demethylases play critical roles in many types of cancer. However the role of m6A-binding proteins in cancer remains elusive. Here we report that the down-regulation of YTHDF2 was specifically induced by hypoxia in hepatocellular carcinoma (HCC) cells, and that overexpression of YTHDF2 suppressed cell proliferation, tumor growth and activation of MEK and ERK in HCC cells. Mechanistically, YTHDF2 directly bound the m6A modification site of EGFR 3'-UTR to promote the degradation of EGFR mRNA in HCC cells. This is the first report showing that YTHDF2 may act as a tumor suppressor to repress cell proliferation and growth via destabilizing the EGFR mRNA in HCC.
Insights
Hypoxia down-regulates YTHDF2 in liver cancer cells. YTHDF2 acts as a tumor suppressor by degrading EGFR mRNA, inhibiting cancer cell growth and proliferation.
Area of Science:
- Molecular Biology
- Oncology
- Epigenetics
Background:
- N6-methyladenosine (m6A) is a prevalent mRNA modification in eukaryotes.
- m6A methyltransferases and demethylases are crucial in cancer development.
- The function of m6A-binding proteins in cancer is largely unknown.
Purpose of the Study:
- To investigate the role of YTHDF2, an m6A-binding protein, in hepatocellular carcinoma (HCC).
- To elucidate the mechanism by which YTHDF2 influences HCC progression.
Main Methods:
- Studied YTHDF2 expression under hypoxic conditions in HCC cells.
- Assessed the effects of YTHDF2 overexpression on HCC cell proliferation, tumor growth, and MEK/ERK signaling.
- Investigated the direct binding of YTHDF2 to EGFR mRNA and its impact on mRNA stability.
Main Results:
- Hypoxia specifically down-regulated YTHDF2 in HCC cells.
- YTHDF2 overexpression suppressed HCC cell proliferation, tumor growth, and MEK/ERK activation.
- YTHDF2 directly bound to the m6A site in EGFR 3'-UTR, promoting EGFR mRNA degradation.
Conclusions:
- YTHDF2 functions as a tumor suppressor in HCC.
- YTHDF2 represses HCC cell proliferation and growth by destabilizing EGFR mRNA.
- YTHDF2 down-regulation by hypoxia may contribute to HCC progression.
More Related Videos
10:18Exploring the Potential of Mesenchymal Stem Cell Sheet on The Development of Hepatocellular Carcinoma In Vivo
Published on: September 11, 2018
10:35Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice
Published on: September 25, 2013
Related Concept Videos
Cells Coordinate Growth and Proliferation
Destabilization of Microtubules
Drugs that Destabilize Microtubules
Regulated mRNA Transport
Nuclear Export of mRNA
pre-mRNA Processing
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl...